1. Fast Simultaneous Determination of 3 Major Components (Ginsenosides Rg1, Rb1, and Rc) after Oral Administration of HAD-B1 in Rats Using the HPLC-MS/MS System
   Lien Thi Ngo et al, 2022, Drug Targets and Therapeutics CrossRef
2. Synergistic Effect of HAD-B1 and Afatinib Against Gefitinib Resistance of Non-Small Cell Lung Cancer
   Si Yeon Song et al, 2022, Integrative Cancer Therapies CrossRef
3. Nonclinical Safety Pharmacology Study of the Herbal Product HAD-B1
   Soo-Dam Kim et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
4. Acute and Subchronic Toxicological Evaluation of the Herbal Product HAD-B1 in Rats
   So-Jung Park et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef